![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
LC Trost and JJ Lemasters
Department of Cell Biology & Anatomy, School of Medicine, University of North Carolina at Chapel Hill, USA.
Aspirin, Neem oil, valproic, adipic, benzoic, isovaleric, 3- mercaptopropionic and 4-pentenoic acids are implicated in the pathogenesis of Reye's syndrome, Jamaican vomiting sickness, and related chemical toxicities. These disorders are characterized by hyperammonemia, hypoglycemia, microvesicular steatosis and encephalopathy. The goal of this study was to determine whether chemicals implicated in Reye's-related disorders induce the mitochondrial permeability translation (MPT). The MPT is induced by opening of a high-conductance, cyclosporin-sensitive pore in the mitochondrial inner membrane, causing swelling, depolarization and uncoupling of oxidative phosphorylation. In freshly isolated rat liver mitochondria, unhydrolyzed aspirin (300 microM) did not induce the MPT in the presence of 50 microM CaCl2. Salicylate, the hydrolysis product of aspirin and its active metabolite, was much more potent causing dose- dependent onset of the MPT in a therapeutic range of concentrations (37.5-300 microM). Similarly, Neem oil and valproic, adipic, benzoic, isovaleric, 3-mercaptopropionic and 4-pentenoic acids induced onset of the MPT. In all cases, cyclosporin A (200 nM), a specific inhibitor of the permeability transition pore, blocked the MPT caused by these inducers. Induction of the MPT by these agents was not caused by mitochondrial depolarization because concentrations of valproic acid and salicylate inducing the MPT had little effect on mitochondrial delta psi. Moreover, equivalent uncoupling caused by 5 nM carbonyl cyanide p-trifluoromethoxyphenylhydrazone did not induce an MPT. These data suggest that induction of the MPT is a common pathophysiological mechanism causing mitochondrial injury in Reye's syndrome and Reye's- related drug toxicities.
This article has been cited by other articles:
|
|
 |
|
  P. D. Cornwell and R. G. Ulrich Investigating the Mechanistic Basis for Hepatic Toxicity Induced by an Experimental Chemokine Receptor 5 (CCR5) Antagonist Using a Compendium of Gene Expression Profiles Toxicol Pathol, June 1, 2007; 35(4): 576 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rotem, A. Heyfets, O. Fingrut, D. Blickstein, M. Shaklai, and E. Flescher Jasmonates: Novel Anticancer Agents Acting Directly and Selectively on Human Cancer Cell Mitochondria Cancer Res., March 1, 2005; 65(5): 1984 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Fosslien Mitochondrial Medicine - Cardiomyopathy Caused by Defective Oxidative Phosphorylation Ann. Clin. Lab. Sci., October 1, 2003; 33(4): 371 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-W. Oh, T. Qian, D. A. Brenner, and J. J. Lemasters Salicylate Enhances Necrosis and Apoptosis Mediated by the Mitochondrial Permeability Transition Toxicol. Sci., May 1, 2003; 73(1): 44 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Szewczyk and L. Wojtczak Mitochondria as a Pharmacological Target Pharmacol. Rev., March 1, 2002; 54(1): 101 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J F T GLASGOW and B MIDDLETON Reye syndrome---insights on causation and prognosis Arch. Dis. Child., November 1, 2001; 85(5): 351 - 353. [Full Text] [PDF]
|
|
|
|
|
|
E. Fosslien Mitochondrial Medicine - Molecular Pathology of Defective Oxidative Phosphorylation Ann. Clin. Lab. Sci., January 1, 2001; 31(1): 25 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Buki, D. O. Okonkwo, K. K. W. Wang, and J. T. Povlishock Cytochrome c Release and Caspase Activation in Traumatic Axonal Injury J. Neurosci., April 15, 2000; 20(8): 2825 - 2834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Masubuchi, S. Yamada, and T. Horie Possible Mechanism of Hepatocyte Injury Induced by Diphenylamine and Its Structurally Related Nonsteroidal Anti-Inflammatory Drugs J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 982 - 987. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Jacotot, L. Ravagnan, M. Loeffler, K. F. Ferri, H. L.A. Vieira, N. Zamzami, P. Costantini, S. Druillennec, J. Hoebeke, J. P. Briand, et al. The HIV-1 Viral Protein R Induces Apoptosis via a Direct Effect on the Mitochondrial Permeability Transition Pore J. Exp. Med., January 3, 2000; 191(1): 33 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Nicholls and S. L. Budd Mitochondria and Neuronal Survival Physiol Rev, January 1, 2000; 80(1): 315 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Guereno, R. A. Diez;, B. Bellosillo, and J. Gil Induction of Apoptosis by Salicylates in B-Cell Chronic Lymphocytic Leukemia Blood, February 1, 1999; 93(3): 1123 - 1124. [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Bradham, T. Qian, K. Streetz, C. Trautwein, D. A. Brenner, and J. J. Lemasters The Mitochondrial Permeability Transition Is Required for Tumor Necrosis Factor Alpha-Mediated Apoptosis and Cytochrome c Release Mol. Cell. Biol., November 1, 1998; 18(11): 6353 - 6364. [Abstract] [Full Text]
|
|
|
|
|
|
I. Marzo, C. Brenner, N. Zamzami, S. A. Susin, G. Beutner, D. Brdiczka, R. Remy, Z.-H. Xie, J. C. Reed, and G. Kroemer The Permeability Transition Pore Complex: A Target for Apoptosis Regulation by Caspases and Bcl-2-related Proteins J. Exp. Med., April 20, 1998; 187(8): 1261 - 1271. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
